SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (12259)11/18/1999 8:38:00 AM
From: Arthur Radley  Read Replies (1) | Respond to of 17367
 
IF XOMA can bring their product to the market at least one competitor has dropped from the race today:SOUTH SAN FRANCISCO, Calif., Nov 18 (Reuters) - Axys Pharmaceuticals Inc. said Thursday it has discontinued further development of a topical cream-based formulation of APC-2059 for psoriasis after there was no difference between placebo and treated sites of skin disease in a first stage phase II study initiated in May 1